Crohn's Disease - A chronic condition inflammation of the gastrointestinal tract . Inflammation affects all departments - from the mouth to the rectum. The cause of the disease is not known reliably. Presumably, it may be genetic, infectious or immunologic factors.
Study leader, Dr. William Dzh.Sandborn, collaborating with the Mayo Clinic in Rochester, Minnesota, says that the new discovery may change the usual understanding of the treatment Crohn's disease .
Now this treatment begins with steroids. If relief does not occur, the drug is used " azathioprine ", That reduces the activity of the immune system in general. And then apply other biologics.
Researchers have shown that the application stage azathioprine It shall be passed. Treatment of Crohn's disease shall include the use of steroids and biologics. According to doctors, this is the most effective strategy combination therapy .
In the study, researchers took part in 508 patients Crohn's disease . After applying the new combination therapy in patients with remission of symptoms. In comparison, in patients receiving azathioprine , Remission occurs in 30 percent of cases. Scientists have come to the conclusion that Combination therapy more effective. It helps protect against infections resulting from the weakening of the walls of the intestine due to illness.
Industry News
Go back to the main page
No comments:
Post a Comment